CN116036222A - 一种活络祛风姜泥膏及其制备方法 - Google Patents
一种活络祛风姜泥膏及其制备方法 Download PDFInfo
- Publication number
- CN116036222A CN116036222A CN202310070037.0A CN202310070037A CN116036222A CN 116036222 A CN116036222 A CN 116036222A CN 202310070037 A CN202310070037 A CN 202310070037A CN 116036222 A CN116036222 A CN 116036222A
- Authority
- CN
- China
- Prior art keywords
- extract
- paste
- ginger
- preservative film
- wind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003213 activating effect Effects 0.000 title claims abstract description 21
- 235000006886 Zingiber officinale Nutrition 0.000 title claims description 32
- 235000008397 ginger Nutrition 0.000 title claims description 32
- 238000002360 preparation method Methods 0.000 title description 10
- 244000273928 Zingiber officinale Species 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 27
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000013871 bee wax Nutrition 0.000 claims abstract description 17
- 239000012166 beeswax Substances 0.000 claims abstract description 17
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004264 Petrolatum Substances 0.000 claims abstract description 16
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002480 mineral oil Substances 0.000 claims abstract description 16
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 16
- 229940066842 petrolatum Drugs 0.000 claims abstract description 16
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 15
- 239000004200 microcrystalline wax Substances 0.000 claims abstract description 14
- 235000019808 microcrystalline wax Nutrition 0.000 claims abstract description 14
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 13
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 13
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 13
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 13
- 241000405414 Rehmannia Species 0.000 claims abstract description 13
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical class C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940069445 licorice extract Drugs 0.000 claims abstract description 13
- 229920003048 styrene butadiene rubber Polymers 0.000 claims abstract description 13
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims abstract description 13
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims abstract description 12
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims abstract description 12
- 229950011392 sorbitan stearate Drugs 0.000 claims abstract description 12
- 229940078465 vanillyl butyl ether Drugs 0.000 claims abstract description 12
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 10
- 229960002216 methylparaben Drugs 0.000 claims abstract description 10
- 241000202726 Bupleurum Species 0.000 claims abstract description 9
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims abstract description 8
- 229940076591 saffron extract Drugs 0.000 claims abstract description 8
- 241000234314 Zingiber Species 0.000 claims description 31
- 239000003755 preservative agent Substances 0.000 claims description 24
- 230000002335 preservative effect Effects 0.000 claims description 24
- 239000001993 wax Substances 0.000 claims description 13
- 241000207925 Leonurus Species 0.000 claims description 12
- 238000002844 melting Methods 0.000 claims description 9
- 230000008018 melting Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 235000015655 Crocus sativus Nutrition 0.000 claims description 5
- 244000124209 Crocus sativus Species 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 16
- 239000011505 plaster Substances 0.000 abstract description 5
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 208000017667 Chronic Disease Diseases 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 3
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 238000010409 ironing Methods 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 239000009849 Bupleurum root extract Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 3
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- -1 carotene compounds Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
Abstract
本发明涉及膏药技术领域,目的是提供一种活络祛风姜泥膏,包括以下组分:矿油、棕榈酸乙基己酯、艾叶提取物、矿脂、蜂蜡、火山泥、益母草粉、番红花提取物、柴胡提取物、姜根提取物、甘草提取物、地黄提取物、熔岩粉、山梨坦硬脂酸酯、香兰基丁基醚、氢化苯乙烯/丁二烯共聚物、羟苯甲酯、微晶蜡。本发明通过在人体特定部位用药热灼或熨烫刺激,可随意贴敷身体的任何部位,具有舒筋活络、祛风除湿、镇痛等多重功效,能迅速打通人体经络,将体内的风寒湿邪驱出体外,达到快速治愈顽疾的目的,对皮肤无副作用。
Description
技术领域
本发明涉及膏药技术领域,更具体地说,它涉及一种活络祛风姜泥膏及其制备方法。
背景技术
随着社会经济的发展,人们生活水平在不断提高,其工作节奏也在不断地加快,使得体育锻炼的机会较少,而且大多从事伏案工作,使得较多25-65年龄段的上班族遭遇关节疼痛的折磨,再加上夏季在空调室内吹冷风时间长了以后,会出现筋骨疼痛、四肢麻木,腰背沉重、行走不便、骨关节变形等症状。
对于上述症状,人们大多采用服用西药或采取按摩推拿的治疗方式,但按摩推拿需要专业人员才能获得较好的效果,而且只能起到病情缓解的作用;而止疼类药品一般具有或大或小的副作用,不适合长期服用。
发明内容
针对现有技术存在的不足,本发明的目的是提供一种活络祛风姜泥膏及其制备方法;本申请的活络祛风姜泥膏通过在人体特定部位用药热灼或熨烫刺激,可随意贴敷身体的任何部位,具有舒筋活络、祛风除湿、镇痛等多重功效,能迅速打通人体经络,将体内的风寒湿邪驱出体外,达到快速治愈顽疾的目的,对皮肤无副作用。
为实现上述目的,本发明采用如下技术方案:
一种活络祛风姜泥膏,,包括以下组分:矿油、棕榈酸乙基己酯、艾叶提取物、矿脂、蜂蜡、火山泥、益母草粉、番红花提取物、柴胡提取物、姜根提取物、甘草提取物、地黄提取物、熔岩粉、山梨坦硬脂酸酯、香兰基丁基醚、氢化苯乙烯/丁二烯共聚物、羟苯甲酯、微晶蜡。
可选的,包括以下重量百分比组分:矿油8-15%、棕榈酸乙基己酯8-15%、艾叶提取物8-15%、矿脂8-15%、蜂蜡8-15%、火山泥6-12%、益母草粉1-5%、番红花提取物1-5%、柴胡提取物1-5%、姜根提取物1-5%、甘草提取物1-5%、地黄提取物1-5%、熔岩粉1-5%、山梨坦硬脂酸酯0.2-0.8%、香兰基丁基醚0.1-0.5%、氢化苯乙烯/丁二烯共聚物0.1-0.5%、羟苯甲酯0.1-0.5%、微晶蜡余量。
可选的,包括以下重量百分比组分:矿油10%、棕榈酸乙基己酯10%、艾叶提取物10%、矿脂10%、蜂蜡10%、火山泥9.7%、益母草粉2%、番红花提取物2%、柴胡提取物2%、姜根提取物2%、甘草提取物2%、地黄提取物2%、熔岩粉2%、山梨坦硬脂酸酯0.5%、香兰基丁基醚0.3%、氢化苯乙烯/丁二烯共聚物0.2%、羟苯甲酯0.2%、微晶蜡余量。
本发明的另一目的是提供一种活络祛风姜泥膏的制备方法,可选的包括以下步骤:
S1:按重量比称取各组分,将矿油、棕榈酸乙基己酯、矿脂及蜂蜡混合,进行文火融化,融化为液体状态后,得到混合蜡;
S2:将火山泥和熔岩粉加入到混合蜡中,搅拌均匀,保温,得到混合泥膏;
S3:将其余组分加入到混合泥膏中,搅拌至混合均匀,直至无气泡产生进行灌装,得到所述的活络祛风姜泥膏。
可选的,步骤S2中的保湿时间为30-45分钟。
本发明的又一目的是提供的一种活络祛风姜泥膏的使用方法,可选的包括如下步骤:
加热泥膏:将盛放有活络祛风姜泥膏的包装盒放入微波炉中,“高火”档加热2-3分钟;
涂抹泥膏:在身体上铺上保鲜膜,在保鲜膜上涂上加热后的泥膏,涂敷厚度为1-2个硬币厚;
翻保鲜膜:将保鲜膜翻转,盖于敷药部分,敷药20-40分钟;
常温保存:敷药后,沿着边缘卷起保鲜膜,放于保鲜盒内常温保存,便于下次使用。
本发明中的微晶蜡,是一种近似微晶性质的精制合成蜡,具有光泽好,熔点高,色泽浅的特点,其结构紧密,坚而滑润,能与各种天然蜡互熔,并能提高其低度蜡的熔点,改进粗性蜡的性能。从而缓解因蜡温度过高刺激皮肤产生灼热刺痛感。
本发明中的蜂蜡,热容量大,导热率低,能阻止热的传导;散热慢,气体和水分不易消失。敷药时,可显著延长泥膏的保温时间。蜡具有可塑性,能密贴于体表,还可加入一些其他药物协同进行治疗。此外蜡中的有效成分,还有促进创面的上皮再生的作用;与中药成分结合在一起,可加强细胞膜通透性,减轻组织水肿,产生柔和的机械压迫作用,使皮肤柔软并富有弹性,能改善皮肤营养,加速上皮的生长,利于创面溃疡和骨折的愈合,还具有镇痛解痉作用。
本发明中的火山泥,以深灰到黑色的无黏性泥为主要成分,蕴含三十多种微量元素和矿物质,可以调节身体的免疫能力,可以起到缓解疲劳和消除疼痛的作用,还可以促进身体的血液循环和新陈代谢,并且通过火山泥强力的吸咐与活血化淤作用,可以达到美白肌肤且调节人体微循环的作用。
本发明中的矿油和矿脂,与天然动植物来源的油脂(特别是含有一些不饱和脂类的原料)相比,其性质稳定、安全温和,不会发生天然油脂很容易出现的氧化变质问题。因其不亲水、不被吸收的特性,涂抹在皮肤上能在其表面形成一层膜,使水分不易蒸发散失,可以保持皮肤为湿润状态,阻挡来自空气中的细菌和皮肤接触,从而降低感染的可能性。与微晶蜡、蜂蜡搭配时能保持一种湿热的保温效果,延长毛孔打开时间,使更多中药成分进入到病灶部位。
本发明中的棕榈酸乙基己酯,是一种优良的皮肤柔润剂,性质稳定,不易氧化或产生异味,可使肌肤柔和嫩滑而无油腻的感觉,渗透性好。
本发明中的艾叶提取物,具有温经止血,散寒止痛,降湿杀虫的功效。苦燥辛散,能理气血、温经脉、逐寒湿、止冷痛。
本发明中的益母草提取物,味辛苦、凉,活血、祛淤、调经、消水。其含有硒和锰等微量元素,可抗氧化、防衰老、抗疲劳及抑制癌细胞增生。
本发明中的番红花提取物,含有胡萝卜素类化合物,其中主要为番红花甙、番红花酸二甲酯,番红花苦甙及挥发油;活血化瘀,凉血解毒、散瘀止痛,解郁安神,用作镇静、驱风、止痛剂。
本发明中的柴胡提取物,味苦,性凉。主要的功效是疏风清热、镇静安神、抗病毒等。
本发明中的姜根提取物,破血行气,通经止痛。用于胸胁刺痛,胸痹心痛,痛经经闭,癥瘕,风湿肩臂疼痛,跌扑肿痛。
本发明中的甘草提取物,补脾益气、清热解毒、祛痰止咳、缓急止痛,调和诸药。用于脾胃虚弱、倦怠乏力、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性等。
本发明中的地黄提取物,清热凉血、养阴生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血,传染性肝炎。
本发明的有益效果在于:
(1)姜泥膏体可以很好的吸热和保温,并且散热均匀,可以方便的贴敷在人体的不同部位,且可以重复加热使用,具有舒筋活络、祛风除湿、镇痛等多重功效,能迅速打通人体经络,将体内的风寒湿邪驱出体外,达到快速治愈顽疾的目的,对皮肤无副作用。
(2)添加了适量氢化苯乙烯/丁二烯共聚物后,无毒无害,可以改善灸泥的密封性、抗拉性、抗干裂性,滋润不油腻,保湿润滑,渗透力强,从而获得更好的使用效果。
(3)添加的火山泥具有强力的吸附和活血化瘀的作用,可以调节人体的微循环、激活皮肤细胞、使皮肤组织再生,同时火山泥中的各种矿物质与微量元素会被人体吸收,对人体脏器与关节均有修复作用。
具体实施方式
下面结合实施例对本发明作进一步的描述,但本发明要求保护的范围并不局限于实施例表述的范围。
实施例1
一种活络祛风姜泥膏,包括以下重量百分比组分:矿油8%、棕榈酸乙基己酯8%、艾叶提取物8%、矿脂8%、蜂蜡8%、火山泥6%、益母草粉1%、番红花提取物1%、柴胡提取物1%、姜根提取物1%、甘草提取物1%、地黄提取物1%、熔岩粉1%、山梨坦硬脂酸酯0.2%、香兰基丁基醚0.1%、氢化苯乙烯/丁二烯共聚物0.1%、羟苯甲酯0.1%、微晶蜡补足至100%。
上述活络祛风姜泥膏的制备方法,包括以下步骤:
S1:按重量比称取各组分,将矿油、棕榈酸乙基己酯、矿脂及蜂蜡混合,进行文火融化,融化为液体状态后,得到混合蜡;
S2:将火山泥和熔岩粉加入到混合蜡中,搅拌均匀,保温30-45分钟,得到混合泥膏;
S3:将其余组分加入到混合泥膏中,搅拌至混合均匀,直至无气泡产生进行灌装,降至常温后,得到所述的活络祛风姜泥膏。
上述活络祛风姜泥膏的使用方法为:
加热泥膏:将盛放有活络祛风姜泥膏的包装盒打开,放入美的微波炉中,设置“高火”档位加热2-3分钟;观察搅拌均匀,根据融化程度和自身感热使用。
涂抹泥膏:在身体上铺上保鲜膜,在保鲜膜上均匀涂上加热后的泥膏,涂敷厚度为1-2个硬币厚。
翻保鲜膜:将保鲜膜翻转,盖于敷药部分,敷药20-40分钟;具体时间依2个人体质、热感舒适而定。
常温保存:敷药后,沿着边缘卷起保鲜膜,放于保鲜盒内常温保存,便于下次使用,一般可重复使用10-15次。
实施例2
一种活络祛风姜泥膏,包括以下重量百分比组分:矿油15%、棕榈酸乙基己酯15%、艾叶提取物15%、矿脂15%、蜂蜡15%、火山泥12%、益母草粉5%、番红花提取物5%、柴胡提取物5%、姜根提取物5%、甘草提取物5%、地黄提取物5%、熔岩粉5%、山梨坦硬脂酸酯0.8%、香兰基丁基醚0.5%、氢化苯乙烯/丁二烯共聚物0.5%、羟苯甲酯0.5%、微晶蜡补足至100%。
上述活络祛风姜泥膏的制备方法及使用方法与实施例1相同。
实施例3
一种活络祛风姜泥膏,包括以下重量百分比组分:矿油10%、棕榈酸乙基己酯10%、艾叶提取物10%、矿脂10%、蜂蜡10%、火山泥9.7%、益母草粉2%、番红花提取物2%、柴胡提取物2%、姜根提取物2%、甘草提取物2%、地黄提取物2%、熔岩粉2%、山梨坦硬脂酸酯0.5%、香兰基丁基醚0.3%、氢化苯乙烯/丁二烯共聚物0.2%、羟苯甲酯0.2%、微晶蜡补足至100%。
上述活络祛风姜泥膏的制备方法及使用方法与实施例1相同。
实施例4
一种活络祛风姜泥膏,包括以下重量百分比组分:矿油15%、棕榈酸乙基己酯15%、艾叶提取物8%、矿脂15%、蜂蜡15%、火山泥12%、益母草粉1%、番红花提取物1%、柴胡提取物1%、姜根提取物1%、甘草提取物1%、地黄提取物1%、熔岩粉1%、山梨坦硬脂酸酯0.2%、香兰基丁基醚0.1%、氢化苯乙烯/丁二烯共聚物0.1%、羟苯甲酯0.1%、微晶蜡补足至100%。
上述活络祛风姜泥膏的制备方法及使用方法与实施例1相同。
实施例5
一种活络祛风姜泥膏,包括以下重量百分比组分:矿油8%、棕榈酸乙基己酯8%、艾叶提取物15%、矿脂8%、蜂蜡8%、火山泥6%、益母草粉2%、番红花提取物3%、柴胡提取物2%、姜根提取物3%、甘草提取物2%、地黄提取物2%、熔岩粉2%、山梨坦硬脂酸酯0.8%、香兰基丁基醚0.5%、氢化苯乙烯/丁二烯共聚物0.4%、羟苯甲酯0.2%、微晶蜡补足至100%。
上述活络祛风姜泥膏的制备方法及使用方法与实施例1相同。
应用例
刘某,女、32岁,每工作日需长时间伏案在电脑前的财务人员,肩关节经常疼痛,每天睡前敷贴实施例3中的姜泥膏,连续敷贴7天为一个疗程,敷贴一个疗程后症状缓解明显,敷贴四个疗程后症状体征基本消失。
徐某,男、55岁,工地电工人员,腰痛、腿痛,四肢乏力,每天睡前敷贴实施例3中的姜泥膏,连续敷贴7天为一个疗程,敷贴一个疗程后症状减轻,敷贴四个疗程后症状体明显好转,继续敷贴四个疗程后症状体征基本消失。
陈某,男、42岁,高中教师,患颈椎病及肩周炎,每天睡前敷贴实施例3中的姜泥膏,连续敷贴7天为一个疗程,敷贴一个疗程后症状缓解明显,敷贴四个疗程后症状体征基本消失。
林某,男、28岁,海边捕鱼人员,患风湿性腰腿痛,每天睡前敷贴实施例3中的姜泥膏,连续敷贴7天为一个疗程,敷贴一个疗程后症状缓解明显,敷贴四个疗程后症状体征基本消失,后续出海前后各敷贴一次,三年间未见复发。
王某,男、60岁,年轻时为冷库工作人员,患漆关节痛,且行走不便,常年吃止痛药,经多次推拿也未见治愈;每天睡前敷贴实施例3中的姜泥膏,连续敷贴7天为一个疗程,敷贴一个疗程后症状缓解有所缓解,敷贴四个疗程后症状大大减轻,继续服用四个疗程后,症状体征基本消失,一年内随访无复发。
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (6)
1.一种活络祛风姜泥膏,其特征在于,包括以下组分:矿油、棕榈酸乙基己酯、艾叶提取物、矿脂、蜂蜡、火山泥、益母草粉、番红花提取物、柴胡提取物、姜根提取物、甘草提取物、地黄提取物、熔岩粉、山梨坦硬脂酸酯、香兰基丁基醚、氢化苯乙烯/丁二烯共聚物、羟苯甲酯、微晶蜡。
2.根据权利要求1所述的活络祛风姜泥膏,其特征在于,包括以下重量百分比组分:矿油8-15%、棕榈酸乙基己酯8-15%、艾叶提取物8-15%、矿脂8-15%、蜂蜡8-15%、火山泥6-12%、益母草粉1-5%、番红花提取物1-5%、柴胡提取物1-5%、姜根提取物1-5%、甘草提取物1-5%、地黄提取物1-5%、熔岩粉1-5%、山梨坦硬脂酸酯0.2-0.8%、香兰基丁基醚0.1-0.5%、氢化苯乙烯/丁二烯共聚物0.1-0.5%、羟苯甲酯0.1-0.5%、微晶蜡余量。
3.根据权利要求1所述的活络祛风姜泥膏,其特征在于,包括以下重量百分比组分:矿油10%、棕榈酸乙基己酯10%、艾叶提取物10%、矿脂10%、蜂蜡10%、火山泥9.7%、益母草粉2%、番红花提取物2%、柴胡提取物2%、姜根提取物2%、甘草提取物2%、地黄提取物2%、熔岩粉2%、山梨坦硬脂酸酯0.5%、香兰基丁基醚0.3%、氢化苯乙烯/丁二烯共聚物0.2%、羟苯甲酯0.2%、微晶蜡余量。
4.一种根据权利要求1-3任一项所述的活络祛风姜泥膏的制备方法,其特征在于,包括以下步骤:
S1:按重量比称取各组分,将矿油、棕榈酸乙基己酯、矿脂及蜂蜡混合,进行文火融化,融化为液体状态后,得到混合蜡;
S2:将火山泥和熔岩粉加入到混合蜡中,搅拌均匀,保温,得到混合泥膏;
S3:将其余组分加入到混合泥膏中,搅拌至混合均匀,直至无气泡产生进行灌装,得到所述的活络祛风姜泥膏。
5.根据权利要求4所述的活络祛风姜泥膏的制备方法,其特征在于,步骤S2中的保湿时间为30-45分钟。
6.一种根据权利要求1-3任一项所述的活络祛风姜泥膏的使用方法,其特征在于,包括如下步骤:
加热泥膏:将盛放有活络祛风姜泥膏的包装盒放入微波炉中,“高火”档加热2-3分钟;
涂抹泥膏:在身体上铺上保鲜膜,在保鲜膜上涂上加热后的泥膏,涂敷厚度为1-2个硬币厚;
翻保鲜膜:将保鲜膜翻转,盖于敷药部分,敷药20-40分钟;
常温保存:敷药后,沿着边缘卷起保鲜膜,放于保鲜盒内常温保存,便于下次使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310070037.0A CN116036222A (zh) | 2023-02-07 | 2023-02-07 | 一种活络祛风姜泥膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310070037.0A CN116036222A (zh) | 2023-02-07 | 2023-02-07 | 一种活络祛风姜泥膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116036222A true CN116036222A (zh) | 2023-05-02 |
Family
ID=86121739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310070037.0A Pending CN116036222A (zh) | 2023-02-07 | 2023-02-07 | 一种活络祛风姜泥膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116036222A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109529001A (zh) * | 2019-01-04 | 2019-03-29 | 娄底市龙山中草药研究有限公司 | 一种中药泥灸及其制备和使用方法 |
CN110464779A (zh) * | 2018-05-12 | 2019-11-19 | 程勇 | 一种可治病防病的艾灸泥药膏及其制备方法 |
-
2023
- 2023-02-07 CN CN202310070037.0A patent/CN116036222A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110464779A (zh) * | 2018-05-12 | 2019-11-19 | 程勇 | 一种可治病防病的艾灸泥药膏及其制备方法 |
CN109529001A (zh) * | 2019-01-04 | 2019-03-29 | 娄底市龙山中草药研究有限公司 | 一种中药泥灸及其制备和使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102258746B (zh) | 烧烫伤创面处理软膏 | |
WO2012100754A1 (zh) | 一种治疗刀伤、烧伤及多种创伤中药组合物 | |
CN106620622A (zh) | 一种艾灸组合物及其制备方法和应用 | |
CN103251707A (zh) | 用于消除疤痕的中药组合物及其制备方法 | |
CN110339325A (zh) | 一种治疗痹症的外用药酒及其制备方法 | |
CN103385941A (zh) | 中草药止痛药炙 | |
CN116036222A (zh) | 一种活络祛风姜泥膏及其制备方法 | |
CN108578588A (zh) | 一种筋骨疼痛贴及其制造方法 | |
CN104435783A (zh) | 能量养生灸及其使用方法 | |
CN103977367A (zh) | 一种治疗气滞癖血型褥疮的中药及制备方法 | |
CN111658711A (zh) | 一种治疗烧烫伤的中药配方 | |
CN106038726A (zh) | 一种活血止痛散 | |
CN104958735A (zh) | 一种治疗风湿性关节炎的中药 | |
CN110339264A (zh) | 一种治疗烧伤烫伤的药膏 | |
CN104873723B (zh) | 一种含肉桂油的烧烫伤药 | |
CN110269902A (zh) | 一种治疗烧伤的膏药及其制备方法 | |
CN108969579A (zh) | 一种治疗颈肩腰腿疼痛的外用药膏 | |
CN108653631A (zh) | 一种涂抹式膏药及其制备方法 | |
CN105267376A (zh) | 速恭康酊纯中草药抗菌剂 | |
CN103877228A (zh) | 治疗烧烫伤的药物 | |
CN107029073A (zh) | 一种用于治疗肩颈、腰椎疼痛的中药配方及其制备方法 | |
CN110478421A (zh) | 一种治疗痛风病的中药制剂及其制备方法 | |
CN101357153B (zh) | 无疤烧烫伤药及其制备方法 | |
CN106728069A (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
CN107375723A (zh) | 一种黑膏药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |